Investor Presentaiton
FY22 Financial Results - Investor Presentation
Financial
Performance
Record revenue, operating expenses optimised
Revenue growth of +48% driven by Whispir partnering
with major healthcare providers to deliver personalised
communications during Australia's pandemic response
-
-
Gross margin 58.5%, down slightly from 59.8% PCP
due to larger mix of transactional revenue as a % of
total revenue
Operating expenses growth of 61% reflecting investment
in the product roadmap and sales and marketing
For the year ended 30 June
Total revenue
Cost of services
Gross profit
Gross margin %
2022
$'000
2021
$'000
Change
$'000
Change
%
70,623
47,731
22,892
48%
(29,331)
(19,173)
(10,158)
53%
41,292
28,558
12.734
45%
58.5%
59.8%
NA
-2%
Operating expenses
(60,724)
(37,828)
(22,896)
61%
Net interest and income tax expense
(4)
(384)
380
-99%
Net loss after tax
(19,436)
(9,654)
(9,782)
101%
6,822
3,977
2,845
72%
4
385
(381)
-99%
Add back: share-based payments
2,031
1,523
508
33%
EBITDA (excluding non-cash share-based payments)
(10,579)
(3,769)
(6,810)
181%
Add back: depreciation and amortisation
Add back: net interest and tax
-
EBITDA* of $(10.6)m, up from $(3.8)m PCP.
*Excluding share-based payments
whispir
017View entire presentation